01 — At a Glance
The Specialty Chemical Company That Specializes in Losing Money
- 52-Week High / Low₹335 / ₹112
- Q3 FY26 Revenue₹457 Cr
- Q3 FY26 Loss-₹37 Cr
- TTM EPS-₹3.22
- Book Value / Share₹46.3
- Price to Book2.43x
- ROE (3-Yr)-6.69%
- Return (1-Year)-31.4%
- Return (3-Month)-24.3%
- Debt / Equity0.76x
Flash Summary: Camlin Fine Sciences is a ₹2,175 crore specialty chemicals company that makes the additives keeping your food shelf-stable, your pet food digestible, and your great-grandma’s achaar immortal. In Q3 FY26, they lost ₹37 crores. They have negative earnings for three years running. Their Brazil facility caught fire in Feb 2026. They then used money they don’t have to buy a French vanillin company. And the stock trades at a P/E of 916x. Now read the rest of this article if you enjoy financial horror stories told by comedians.
02 — Introduction
The Company That Makes Chemicals That Keep Your Samosas From Rotting (And Is Itself Rotting)
Let’s be brutally honest. Camlin Fine Sciences makes shelf-life solutions. Translation: the antioxidants, preservatives, and additives that sit between your food and the garbage bin. If you’ve ever wondered why the wafer in your samosa survives three months in a retail shelf under a fluorescent light the size of a small sun, Camlin wrote that recipe.
The company operates across four verticals: Shelf-Life Solutions (72% of FY24 revenue, a.k.a. the company that should save it but won’t), Performance Chemicals (26%), Aroma Ingredients — which is vanillin, ethyl vanillin, and stuff that smells like chocolate (2%), and a random health-and-wellness segment that nobody asked for.
Camlin has 61,000 MT of global capacity, operations in 80+ countries, customers like Cargill and Shell, and a 50% global market share in TBHQ and BHA antioxidants. On paper, this looks like a $1 billion company masquerading in a ₹2,175 crore market cap.
In reality? The company lost ₹37 crores in Q3 alone. TTM earnings are negative ₹3.22. The 3-year ROE is -6.69%. A fire in Brazil in February 2026 destroyed inventory and equipment. And management’s solution? Buy a French specialty chemical company called Vinpai. Because when your house is on fire, the best solution is to take a second mortgage and buy your neighbor’s house.
⚠️ Fitch Rating Note (Jan 2026): Bank facilities downgraded from BBB to BBB- (Stable outlook). Why? Because negative earnings, negative ROE, and structural losses in European operations suggest the company is in transition. Fitch’s polite way of saying: “We’re watching to see if they implode.”
03 — Business Model: WTF Do They Even Do?
Additives, Preservatives, and Vanillin. Also, Apparently, Losing ₹180+ Crores a Year.
Camlin Fine Sciences is a specialty chemicals manufacturer with two profitable businesses and one or two unprofitable ones.
Straights (26% of FY24 revenue): TBHQ and BHA — traditional antioxidants used in food, cosmetics, and pet food. Camlin owns 50% of the global market. They make these by the ton and sell them to every major food company. Margins are normally decent. But in Q3, intense competition in India crushed prices. Management literally said the quarter was “a bit tepid” — which is the corporate equivalent of “we got rekt.”
Blends (46% of FY24 revenue): Custom formulations. Think of it as “Straights+.” They buy TBHQ, BHA, and other chemicals, mix them to customer spec, and sell at higher margins. This is the growth segment. Q3 saw Blends revenue at ₹271 crores, up 11% YoY. It’s the only vertical that’s actually working. Naturally, they also have this segment in Brazil, which recently caught fire.
Performance Chemicals (26% of FY24): Chloranil, MEHQ, HQEE — niche chemicals used in dyes, pharmaceuticals, and energy storage. There’s a long-term supply deal with Lockheed Martin. But execution has been… let’s call it “selective.”
Aroma Ingredients (2% of FY24, the new shiny toy): Vanillin and ethyl vanillin. Real vanilla costs ₹100,000+ per kg. Vanillin is synthetic vanilla, costs ₹8–10 per kg, and tastes nearly identical. Camlin has integrated manufacturing (catechol to vanillin). Q3 saw vanillin sales of ₹55 crores. Management spoke extensively in the concall about US tariff mechanics, duty reductions, and channel inventory — basically admitting they deferred sales to capture better pricing when US duties drop from 25% to 18%. That’s not a growth strategy. That’s a bet on US trade policy.
The Vanillin Play, Explained: US market price is $18–19/kg. But with 25% import duty, Camlin’s effective realization was only $12–12.5/kg. Once duty drops to 18% (expected post-trade-deal), they’ll realize $14–14.5/kg. Management says they intentionally held back ~200 tons in Q3 to wait for the duty drop. Translation: we’re betting our quarterly earnings on US trade policy. Could work. Could be disaster.
04 — Financials Overview
Q3 FY26: The Quarter That Taught Us Loss Can Be Beautiful
Result type: Quarterly Results | Q3 FY26 Net Profit: -₹37 Cr | Annualised EPS (Q1-Q3 avg): (0.83 – 1.03 – 1.89) / 3 = -0.70 × 4 = -₹2.79 (estimated annualized)
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 457 | 431 | 460 | +6.0% | -0.7% |
| Operating Profit | 22 | 56 | 33 | -60.7% | -33.3% |
| OPM % | 5% | 13% | 7% | -800 bps | -200 bps |
| Net Loss | -37 | -7 | -15 | -428.6% | -146.7% |
| EPS (₹) | -1.89 | -0.22 | -0.76 | -758.6% | -148.7% |
⚠️ The Q3 Disaster Remix: Revenue was almost flat (+6% YoY but -0.7% QoQ). Operating profit collapsed from ₹56 crores (Q3 FY25) to ₹22 crores. Net loss was ₹37 crores. How does a company with ₹457 crores revenue lose ₹37 crores? Welcome to Camlin. The answer: depreciation (₹17 crores), interest (₹18 crores), and “Other Income” being -₹24 crores. That -₹24 crores “Other Income” is basically the company losing money on forex, investments, and unspecified sundry items. It’s the financial equivalent of your car’s check-engine light flashing while you’re doing 120 on the highway.
💬 The vanillin tariff play: genius strategy or management using quarterly earnings as a poker chip on US trade policy? What’s your take?
05 — Valuation Discussion: What Is This Stock Actually Worth?
The P/E Is 916x. The Company’s Earnings Are Negative. Let’s Talk About This.
